United States · Bill · S
S. 1323 (94th)
Federal Drug Compendium Act
Introduced
24 March 1975
Last action
—
Status
Referred to Senate Committee on Labor and Public Welfare.
Sponsors
—
Subjects
Discovery layer
Source updated
2 September 2025
Summary
Federal Drug Compendium Act - Revises the Federal Food, Drug, and Cosmetic Act. Directs the Secretary of Health, Education, and Welfare to prepare a drug compendium to be distributed to all practitioners licensed by law to administer and prescribe drugs. Provides that the Secretary shall revise and keep current such compendium. States that the compendium shall list the established name of all drugs lawfully available in the United States and their ingredients. Directs that such compendium shall also include the proprietary names of such drugs and the names of suppliers. Allows the Secretary to issue a supplement to the compendium containing price information. Provides that the Secretary shall not be required to include in the compendium any information concerning drugs of questionable safety. Establishes procedures to insure that any person adversely affected by the Secretary's inclusion or failure to include a drug in the compendium is given due process of law. Provides for the establishment of an advisory committee within the Department of Health, Education, and Welfare to advise the Secretary on matters pertaining to the compendium. Authorizes the Secretary to require persons engaged in manufacturing, preparing, distributing or importing drugs to furnish any available information to the Secretary relating to such drugs. Empowers the Secretary to require that such persons establish and maintain records of clinical experience and other such data relevant to such drugs. Gives the Secretary authority to waive any requirement that the package from which the drug is to be dispensed have on it labeling bearing information adequate for the safe use or prescribing of the drug by licensed practitioners. States that a drug listed in the compendium which has advertising or labeling inconsistent with the compendium description shall not by reason of such inconsistency be deemed misbranded if such label is in full conformity with other applicable regulations contained in the Federal Food, Drug, and Cosmetic Act.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Introduced in Senate
summary · EN · 24 March 1975
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.congress.gov/bill/94th-congress/senate-bill/1323
- Open data entity: https://api.congress.gov/v3/bill/94/s/1323